Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels
β Scribed by H. Bohlen; M. Kessler; M. Sextro; V. Diehl; H. Tesch
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 81 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To investigate whether soluble interleukin-2 receptor (sIL-~R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG). Methods. Soluble IL-2R levels were determined by enzyme-linked immunosorbent assay. WG disease activity in 102 patients was a
## Abstract Expression of interleukinβ6 (ILβ6) and ILβ6 receptors has been demonstrated in Hodgkin and ReedβSternberg (H and RS) cells __in vitro__ and __in vivo__. In order to evaluate the clinical significance of ILβ6 serum levels in patients with Hodgkin's disease (HD), we tested the sera of 56